Abstract
Acemetacin (Emflex – Merck) is a new non-steroidal anti-inflammatory drug intended for use in rheumatoid arthritis and postoperative pain and inflammation. The manufacturer claims it is as effective as indomethacin, but with fewer unwanted effects than other NSAIDs studied. It is not licensed for use in osteoarthritis.
Subject
Pharmacology (medical),General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献